Evaluation of utility of immunohistochemistry markers as a tool for objective diagnosis of low-grade myelodysplastic syndrome in routine reporting: Prospective observational study

• Príomhchruthaitheoirí: Richa Juneja (Údar), Haraprasad Pati (Údar), Prasad Dange (Údar), Gopila Gupta (Údar), Manoranjan Mahapatra (Údar), Seema Tyagi (Údar), Renu Saxena (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Wolters Kluwer Medknow Publications, 2022-01-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Purpose: Diagnosis of myelodysplastic syndrome (MDS) primarily relies on the detection of morphological dysplasia in bone marrow. It is subjective and many studies have reported lack of interobserver agreement in reporting. Biopsy is preferred specimen for megakaryocyte assessment. We studied 43 bon...